- Home
- DBRG vs PBH Comparison
DBRG vs PBH Comparison
Compare DBRG & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DBRG | PBH |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | 2016 | 2004 |
Fundamental Metrics
Financial Performance| Metric | DBRG | PBH |
|---|---|---|
| Price | $15.92 | $50.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $16.00 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.2M | 547.0K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.26% | N/A |
| EPS Growth | ★ 557.14 | N/A |
| EPS | ★ 1.18 | 0.61 |
| Revenue | $93,959,000.00 | ★ $975,777,000.00 |
| Revenue This Year | $373.39 | N/A |
| Revenue Next Year | $8.23 | $4.31 |
| P/E Ratio | ★ $13.49 | $84.23 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $8.94 | $42.62 |
| 52 Week High | $15.95 | $71.07 |
Technical Indicators
Market Signals| Indicator | DBRG | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 45.50 |
| Support Level | $15.33 | $47.61 |
| Resistance Level | $15.92 | $50.15 |
| Average True Range (ATR) | 0.04 | 1.86 |
| MACD | -0.00 | -0.29 |
| Stochastic Oscillator | 73.33 | 12.64 |
Price Performance
Historical ComparisonAbout DBRG DigitalBridge Group Inc.
DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.